申请人:Summit Corporation Plc
公开号:US20140073801A1
公开(公告)日:2014-03-13
Disclosed are compounds of formula (I):
or a pharmaceutically acceptable salt, derivative, solvate, isomer, tautomer, N-oxide, ester, prodrug, isotope or protected form thereof, which are of use as OGA inhibitors, for example in the treatment of various conditions and diseases, including neurodegenerative disorders.
公开了以下式(I)的化合物:或其药用盐、衍生物、溶剂合物、异构体、互变异构体、N-氧化物、酯、前药、同位素或其保护形式,这些化合物可用作OGA抑制剂,例如在治疗各种疾病和疾病,包括神经退行性疾病方面。